SC
EXAS

Scotia Capital’s Exact Sciences EXAS Stock Holding History

Scotia Capital’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-34,865
Closed -$3.33M – 887
2021
Q3 		$3.33M Sell
34,865
-904
-3% -$95.4K 0.02% 303
2021
Q2 		$4.45M Buy
35,769
+1,636
+5% +$195K 0.03% 261
2021
Q1 		$4.5M Buy
34,133
+30,057
+737% +$4.11M 0.04% 246
2020
Q4 		$540K Buy
4,076
+329
+9% +$39.8K 0.01% 557
2020
Q3 		$382K Sell
3,747
-87
-2% -$7.51K ﹤0.01% 556
2020
Q2 		$334K Buy
3,834
+79
+2% +$6.31K ﹤0.01% 496
2020
Q1 		$218K Sell
3,755
-478
-11% -$38.8K ﹤0.01% 560
2019
Q4 		$391K Buy
+4,233
New +$372K ﹤0.01% 567

Other funds holding EXAS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Scotia Capital's EXAS Position: Q4 2021 in Review

Scotia Capital sold out of Exact Sciences (EXAS) in Q4 2021, closing a stake of 34,865 shares — an estimated $3.33M sold.

Scotia Capital first reported a position in EXAS in Q4 2019 and held it in 8 quarters. The position peaked at $4.5M in Q1 2021. 596 funds tracked by Wall St. Rank hold EXAS as of Q4 2021.

  • Scotia Capital reported no remaining Exact Sciences position as of Q4 2021 after selling out during the quarter.
  • Scotia Capital sold 34,865 Exact Sciences shares in Q4 2021, an estimated $3.33M.
  • Scotia Capital first reported a position in Exact Sciences in Q4 2019 and held it in 8 quarters.
  • Scotia Capital's Exact Sciences position peaked at $4.5M in Q1 2021.
  • 596 funds tracked by Wall St. Rank held Exact Sciences as of Q4 2021.

Based on Scotia Capital's 13F filing for Q4 2021, filed 11 Feb 2022.